Publikationen von R. Rupprecht
Alle Typen
Zeitschriftenartikel (107)
2019
Zeitschriftenartikel
67, S. E324 - E324 (2019)
Astrocytes prime an early synaptic pruning and remodelling in the prefrontal cortex upon antidepressant treatment. GLIA 2018
Zeitschriftenartikel
19 (6), 1740 (2018)
Classical Risk Factors and Inflammatory Biomarkers: One of the Missing Biological Links between Cardiovascular Disease and Major Depressive Disorder. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2016
Zeitschriftenartikel
105, S. 154 - 163 (2016)
Desipramine targets astrocytes to attenuate synaptic plasticity via modulation of the ephrinA3/EphA4 signalling. NEUROPHARMACOLOGY 2015
Zeitschriftenartikel
10 (8), S. 1061 - 1065 (2015)
Sexual motivation is reflected by stimulus-dependent motor cortex excitability. SOCIAL COGNITIVE AND AFFECTIVE NEUROSCIENCE
Zeitschriftenartikel
36 (6), S. 2374 - 2386 (2015)
Connectivity and Functional Profiling of Abnormal Brain Structures in Pedophilia. HUMAN BRAIN MAPPING 2014
Zeitschriftenartikel
17 (6), S. 833 - 843 (2014)
Amygdalohippocampal neuroplastic changes following neuroleptic treatment with quetiapine in first-episode schizophrenia. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
Zeitschriftenartikel
53, S. 76 - 83 (2014)
The influence of Hatha yoga as an add-on treatment in major depression on hypothalamic-pituitary-adrenal-axis activity: A randomized trial. JOURNAL OF PSYCHIATRIC RESEARCH
Zeitschriftenartikel
39, S. 141 - 151 (2014)
Impact on cortisol and antidepressant efficacy of quetiapine and escitalopram in depression. PSYCHONEUROENDOCRINOLOGY 2013
Zeitschriftenartikel
14 (11), S. 1329 - 1335 (2013)
Talking to the Synapse: How Antidepressants Can Target Glial Cells to Reshape Brain Circuits. CURRENT DRUG TARGETS
Zeitschriftenartikel
16 (6), S. 1361 - 1371 (2013)
Lipid raft integrity affects GABA(A) receptor, but not NMDA receptor modulation by psychopharmacological compounds. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
Zeitschriftenartikel
232, S. 161 - 168 (2013)
ACUTE ANTIDEPRESSANT TREATMENT DIFFERENTLY MODULATES ERK/MAPK ACTIVATION IN NEURONS AND ASTROCYTES OF THE ADULT MOUSE PREFRONTAL CORTEX. NEUROSCIENCE
Zeitschriftenartikel
11 (2), S. 171 - 185 (2013)
Targeting Glia Cells: Novel Perspectives for the Treatment of Neuropsychiatric Diseases. CURRENT NEUROPHARMACOLOGY 2012
Zeitschriftenartikel
262, S. S107 - S112 (2012)
Translocator protein (18 kDa) (TSPO) as a therapeutic target for anxiety and neurologic disorders. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
Zeitschriftenartikel
159B (3), S. 310 - 315 (2012)
Lack of association of the 5-HT3A receptor with schizophrenia. American Journal of Medical Genetics Part B-Neuropsychiatric Genetics
Zeitschriftenartikel
12 (4), S. 360 - 370 (2012)
Recent Developments in Potential Anxiolytic Agents Targeting GABA(A)/BzR Complex or the Translocator Protein (18kDa) (TSPO). Current Topics in Medicinal Chemistry
Zeitschriftenartikel
62 (1), S. 209 - 216 (2012)
N-desalkylquetiapine activates ERK1/2 to induce GDNF release in C6 glioma cells: A putative cellular mechanism for quetiapine as antidepressant. Neuropharmacology
Zeitschriftenartikel
24 (1), S. 71 - 81 (2012)
Axonal Regeneration and Neuroinflammation: Roles for the Translocator Protein 18 kDa. Journal of Neuroendocrinology
Zeitschriftenartikel
24 (1), S. 82 - 92 (2012)
Translocator Protein (18 kDa) as a Target for Novel Anxiolytics with a Favourable Side-Effect Profile. Journal of Neuroendocrinology 2011
Zeitschriftenartikel
72 (9), S. 1242 - 1247 (2011)
Major Depressive Disorder is associated with cardiovascular risk factors and Low Omega-3 Index. Journal of Clinical Psychiatry
Zeitschriftenartikel
44 (6), S. 288 - 288 (2011)
Astrocytes and neurons coordinate their responsiveness to antidepressant treatment to modulate synaptic plasticity. Pharmacopsychiatry